Cosopt PF — Medica
reduction of elevated intraocular pressure in patients with ocular hypertension
Preferred products
- generic brimonidine 0.2%/timolol maleate 0.5% ophthalmic solution
- generic dorzolamide 2%/timolol maleate 0.5% ophthalmic solution
- generic dorzolamide 2%/timolol maleate 0.5% ophthalmic solution (generic Cosopt PF)
Initial criteria
- Patient has tried one Step 1 Product (generic brimonidine 0.2%/timolol maleate 0.5% ophthalmic solution, generic dorzolamide 2%/timolol maleate 0.5% ophthalmic solution, or generic dorzolamide 2%/timolol maleate 0.5% ophthalmic solution [generic Cosopt PF])
Approval duration
1 year